Healthcare -
Biotechnology - NASDAQ - US
$ 1.06
7.86 %
$ 74.6 M
Market Cap
-1.58
P/E
SLS - STOCK-BASED COMPENSATION
Stock-based Compensation SLS - SELLAS Life Sciences Group, Inc.
1.39 M
LAST VALUE
17.26%
2 YEAR CAGR
28.61%
5 YEAR CAGR
-5.81%
10 YEAR CAGR